TARA ANDRISIN: Open Payments
NPI 1518988211 · GAINESVILLE, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,940 in 76 payments from 19 companies in 2025. Trend: 2023 $2,086 · 2024 $2,064 · 2025 $1,940
Food & beverage: $1,935Education: $5
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 8 | $275 |
| ABBVIE INC. | 20 | $242 |
| Journey Medical Corporation | 2 | $203 |
| Botanix SB Inc | 7 | $189 |
| Regeneron Healthcare Solutions, Inc. | 8 | $168 |
| Janssen Biotech, Inc. | 4 | $165 |
| GENZYME CORPORATION | 4 | $145 |
| LEO Pharma Inc. | 6 | $145 |
| Amgen Inc. | 2 | $129 |
| Galderma Laboratories, L.P. | 4 | $85 |
Products named: DUPIXENT, SOFDRA, TREMFYA, SKYRIZI, OTEZLA, RINVOQ, ADBRY, ANZUPGO.
Industry payments across FL — which companies pay providers there.
